Target intelligence / Profile preview

dTDP-L-rhamnose biosynthesis enzymes (Rml pathway enzymes)

Target
Rml pathway enzymes
Molecular classification
Enzyme, Glucose-1-phosphate thymidylyltransferase (RmlA), dTDP-D-glucose 4,6-dehydratase (RmlB), dTDP-4-dehydrorhamnose 3,5-epimerase (RmlC), dTDP-4-dehydrorhamnose reductase (RmlD)
01

Overview

The dTDP-L-rhamnose biosynthesis enzymes comprise a conserved four-step metabolic pathway—consisting of RmlA, RmlB, RmlC, and RmlD—responsible for synthesizing dTDP-L-rhamnose from glucose-1-phosphate and dTTP (Giraud & Naismith, 2000, Current Opinion in Structural Biology). This nucleotide sugar serves as a critical precursor for the assembly of the bacterial cell wall, O-antigens, and capsular polysaccharides in many significant human pathogens, including Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Streptococcus pneumoniae (van der Beek et al., 2019, Nature Communications). Because the L-rhamnose biosynthetic pathway is essential for bacterial viability and virulence but is entirely absent in humans and other mammals, these enzymes are highly prioritized as targets for the development of novel, narrow-spectrum antibiotics (Mistou et al., 2016, Journal of Biological Chemistry). Inhibition of any enzyme in the pathway, particularly the epimerase RmlC or the reductase RmlD, results in defective cell wall construction, increased susceptibility to host immune responses, and reduced pathogenicity (Dong et al., 2007, Journal of Molecular Biology). While several experimental small-molecule inhibitors and substrate analogs have been identified through high-throughput screening and structure-based drug design, no therapeutic agents targeting this pathway have yet reached clinical approval (Sivayoganathan et al., 2021, Antibiotics). The specificity of these enzymes to bacteria offers a significant therapeutic window, potentially minimizing off-target effects in human patients while addressing the growing challenge of multi-drug resistant infections.

Other names
Rml pathwaydTDP-rhamnose biosynthetic pathwayRmlA-D enzymesL-rhamnose biosynthesis pathwaydTDP-6-deoxy-L-mannose biosynthesis enzymes
02

Mechanism of action

Inhibition of the sequential enzymatic steps (RmlA through RmlD) prevents the production of dTDP-L-rhamnose, leading to the depletion of essential cell wall components, loss of structural integrity, and attenuation of bacterial virulence.

03

Biological functions

Cell wall biosynthesisCarbohydrate metabolismO-antigen synthesisCapsular polysaccharide assemblyBacterial virulence factor production
04

Disease associations

InfectionBacterial infectionTuberculosisPneumoniaMelioidosis
05

Safety considerations

Potential disruption of beneficial commensal gut microbiotaDevelopment of antimicrobial resistanceLow risk of host toxicity due to the absence of the pathway in mammals
06

Interacting drugs

Thymidine analogs (experimental)

3 more in the full profile.

07

Biomarkers

Bacterial L-rhamnose contentdTDP-L-rhamnose intracellular levelsO-antigen expression levels

Beyond the preview

Go deeper on dTDP-L-rhamnose biosynthesis enzymes (Rml pathway enzymes).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dTDP-L-rhamnose biosynthesis enzymes (Rml pathway enzymes).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call